Status:
COMPLETED
Feasibility Study of a Home Hospitalisation Strategy for Patients With Heart Failure
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Jessa Hospital
Isala
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This feasibility study is part of a larger interregional European project (NWE-Chance) financially supported by the 'Interreg North West Europe' program to develop and validate promising integrated eH...
Detailed Description
Patients participating in the NWE-Chance study will be transferred to their home supported by the integrated home hospitalisation platform and a daily visit by a specialised nurse. The home hospitalis...
Eligibility Criteria
Inclusion
- Patients with known and well assessed chronic heart failure.
- Age\>18 years
- (Indication for) hospital admission for acute decompensated heart failure
- Living within a wide proximity of the hospital (differs per centre)
- Living independently and/or sufficiently supported at home and/or living in nursing homes (or other supported living modalities).
Exclusion
- Indication for IC/CCU admission;
- Contraindication to Chance@Home;
- Mental impairment leading to inability to cooperate;
- Severe comorbidity requiring simultaneous hospital care;
- History of severe liver / kidney disease;
- Unstable blood pressure (systolic blood pressure \<90mmHg);
- Unstable heart rhythm (in case of sinus rhythm, heart rate \>110/min, in case of atrial fibrillation \>150/min);
- Need for intravenous inotropic medication;
- Unstable respiratory condition (sO2 \<90% without additional O2)
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04084964
Start Date
October 1 2020
End Date
December 1 2021
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Hospital
Hasselt, Belgium